Novel Approaches to the Treatment of Hypothyroidism

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Hypothyroidism
Interventions
DRUG

Levothyroxine

"Patients will receive Levothyroxine/Placebo~Levothyroxine/Liothyronine with Liothyronine administered twice daily."

DRUG

Levothyroxine/Liothyronine once daily

Patients will receive Levothyroxine/Liothyronine with Liothyronine administered once daily;

DRUG

Levothyroxine/Liothyronine twice daily

Patients will receive Levothyroxine/Liothyronine with Liothyronine administered twice daily;

Trial Locations (1)

06030

RECRUITING

UConn Health, Farmington

All Listed Sponsors
lead

UConn Health

OTHER